iCAC Device vs ClearRead CT
AI Verdict
Choose iCAC Device if…
Choose iCAC Device if your primary objective is the opportunistic identification and quantification of coronary artery calcium from routine, non-contrast, non-gated chest CT scans already performed for other reasons. This tool is ideal for integrating cardiovascular risk assessment into existing radiology workflows by leveraging incidental findings to aid in early disease detection and risk stratification.
View iCAC Device →Choose ClearRead CT if…
Choose ClearRead CT if your institution requires a comprehensive AI solution for cardiothoracic imaging that excels in both coronary artery calcification analysis and advanced pulmonary nodule detection and characterization. This tool is particularly well-suited for improving diagnostic accuracy, reducing reading times, and streamlining workflows in lung cancer screening programs and general cardiothoracic radiology, offering features like vessel suppression and automated nodule tracking.
View ClearRead CT →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | iCAC Device | ClearRead CT |
|---|---|---|
| Pricing | Contact for pricing | Contact for pricing |
| Deployment | Software as a Medical Device (SaMD), integrates with PACS or DICOM router. Cloud-based (via Carebricks platform). | On-premise (stand-alone server, virtual machine) and Cloud |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
ClearRead CTClearRead CT provides strong, quantifiable evidence of reduced reading times (up to 36%) and improved detection accuracy, directly enhancing the radiologist's workflow efficiency and confidence. Its seamless PACS integration and ability to present 'nodule-only' images without disrupting the existing workflow are key usability advantages.
Clinical Value
ClearRead CTClearRead CT offers a broader clinical value by providing a comprehensive AI suite for both coronary artery calcification analysis and advanced pulmonary nodule detection, characterization, and tracking. This integrated approach addresses two critical cardiothoracic health concerns with proven improvements in diagnostic accuracy and efficiency.
Pricing & Value
iCAC DeviceWhile both require direct contact for pricing, Bunkerhill Health actively led the submission for the new CMS reimbursement code G0680 for algorithmic CAC analysis, establishing a clear payment pathway for health systems. This proactive engagement in securing reimbursement directly enhances the financial value proposition for adopting its technology.
Enterprise Readiness
ClearRead CTClearRead CT offers greater deployment flexibility with both on-premise and cloud options, catering to diverse enterprise IT needs. Its proven track record of deployment across numerous major healthcare institutions, vendor-neutral processing capabilities, and ISO27001 certification demonstrate robust enterprise readiness and security for large-scale integration.
Innovation
ClearRead CTClearRead CT showcases stronger innovation with its patented Vessel Suppression technology, which provides an unimpaired view of the lung and is cleared for concurrent reading, significantly enhancing nodule visualization and diagnostic confidence. Its automated nodule tracking and comparison features also represent advanced capabilities within the imaging workflow.
Support & Docs
ClearRead CTRiverain Technologies provides explicit details on its website regarding customer support channels, including email, phone, and a ticket submission system, along with a resource library containing FAQs, manuals, and workflow documentation. This level of transparency and structured support offerings is superior to Tool A, which provides no specific information on support or documentation.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | iCAC Device | ClearRead CT |
|---|---|---|
| Product Name | iCAC Device | ClearRead CT |
| Company | Bunkerhill Health | RIVERAIN TECHNOLOGIES |
| Primary AI Focus | Detects and quantifies coronary artery calcium (CAC) from routine, non-contrast, non-gated chest CT scans. | Enhances pulmonary nodule detection and coronary artery calcification analysis in CT scans. |
| Input Scan Type for CAC | Routine, non-contrast, non-gated chest CT scans | Ungated, non-contrast CTs |
| Key Outputs/Capabilities | Estimates presence and quantity of coronary artery calcium (CAC), provides visual representation and quantitative estimates (Agatston units, four-category). | Pulmonary Nodule Detection (solid, part-solid, ground glass), Patented Vessel Suppression, Nodule Characterization and Measurement, Automated Nodule Tracking and Comparison, Coronary Artery Calcification (CAC) Scoring. |
| Supported Specialties | Cardiology, Radiology | Cardiology, Pulmonology, Radiology |
| Integration Methods | Integrates with PACS or DICOM router, EHRs via the Carebricks platform. | Seamless PACS Integration / Vendor-neutral processing |
Videos
Demos, reviews, and walkthroughs featuring iCAC Device and ClearRead CT.